KB707-02 A Phase 1/2 Study of Inhaled KB707 in Patients With Advanced Solid Tumor Malignancies Affecting the Lungs by Mary Beth Wilwerding | Sep 3, 2026
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors by Mary Beth Wilwerding | Sep 3, 2026
ULI-EAP-100 Expanded access to ulixertinib (bvd-523) in patients with advanced mapk pathway-altered malignancies by Mary Beth Wilwerding | Sep 2, 2026
